Connect with us

Markets

Canopy Growth Announces Filing of Early Warning Report regarding TerrAscend Corp.

Published

on

Canopy Growth Corporation (“Canopy Growth” or the “Company“) (TSX: WEED) (NASDAQ: CGC) today announced that the Company has filed an early warning report under National Instrument 62-103 in connection with the acquisition of an option (the “Option“) to purchase 1,072,450 common shares (the “Common Shares“) of TerrAscend Corp. (“TerrAscend“), conditional upon the occurrence or waiver of amendments to federal laws of the United States to permit the general cultivation, distribution and possession of marijuana (as defined in 21 U.S.C 802) or to remove the regulation of such activities from the federal laws of the United States (the “Triggering Event“). Upon the occurrence or waiver of the Triggering Event, the Company may exercise the Option and pay the balance of the purchase price in order to acquire the Common Shares subject to the Option.

On January 13, 2021, the Company entered into an agreement with an existing shareholder of TerrAscend to acquire the Option for aggregate consideration of approximately US$10.5 million. The acquisition of the Option resulted in an increase in the Company’s interest in the Common Shares of approximately 0.7% on a partially diluted basis. In addition, since the previous early warning report filed by the Company, the Company has acquired beneficial ownership, control or direction over 22,474,130 Common Share purchase warrants (together with the acquisition of the Option, the “Acquisitions“), representing an increase in the Company’s interest in the Common Shares of approximately 10.9% on a partially diluted basis.

Immediately prior to the Acquisitions, the Company beneficially owned, and exercised control or direction over, 38,890,570 exchangeable shares (the “Exchangeable Shares“) of TerrAscend, representing 100% of the issued and outstanding Exchangeable Shares on a non-diluted basis and approximately 29% of the issued and outstanding Common Shares on a partially-diluted basis, assuming the conversion of the Exchangeable Shares into Common Shares following the occurrence or waiver of the Triggering Event.

Immediately following the Acquisitions, the Company beneficially owns, and exercises control or direction over, 38,890,570 Exchangeable Shares, an aggregate of 22,474,130 Common Share purchase warrants and is deemed to own an aggregate of 1,072,450 Common Shares that are subject to the Option, representing 100% of the issued and outstanding Exchangeable Shares on a non-diluted basis and approximately 39.9% of the issued and outstanding Common Shares on a partially-diluted basis, assuming the conversion of the Exchangeable Shares into Common Shares and the exercise of the warrants and the Option held by the Company.

Assuming the conversion of all proportionate voting shares of TerrAscend and the Exchangeable Shares into Common Shares and the exercise of the warrants and the Option held by the Company following the occurrence or waiver of the Triggering Event, the Company would beneficially own, and exercise control or direction over approximately 26.8% of the issued and outstanding Common Shares.

While the Company currently has no immediate plans or intentions with respect to the securities of TerrAscend, depending on regulatory changes, market conditions, general economic and industry conditions, trading prices, TerrAscend’s business, financial condition and prospects and/or other relevant factors, the Company may develop such plans or intentions in the future and, at such time, may from time to time acquire additional securities, dispose of some or all of the existing or additional securities or may continue to hold the securities of TerrAscend.

A copy of the early warning report filed by the Company will be available under TerrAscend’s profile on SEDAR at www.sedar.com or by contacting the Company at 855 558-9333. The Company’s head office is located at 1 Hershey Drive, Smith Falls, Ontario, K7A 0A8 and TerrAscend’s head office is located at P.O. Box 43125, Mississauga, Ontario L5B 4A7.

About Canopy Growth

Canopy Growth (TSX:WEED,NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States, and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional federally-permissible CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information visit www.canopygrowth.com.

Notice Regarding Forward Looking Statements

This press release contains “forward-looking statements” and “forward-looking information” within the meaning of applicable U.S. and Canadian securities laws (collectively, “forward-looking statements”), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use of such terms and phrases as “intend,” “goal,” “strategy,” “estimate,” “expect,” “project,” “projections,” “forecasts,” “plans,” “seeks,” “anticipates,” “potential,” “proposed,” “will,” “should,” “could,” “would,” “may,” “likely,” “designed to,” “foreseeable future,” “believe,” “scheduled” and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward–looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward–looking statements and the forward-looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth can be found under the section entitled “Risk Factors” in Canopy Growth’s Annual Report on Form 10-K for the year ended March 31, 2020, filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at www.sec.gov/edgar and www.sedar.com, respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward–looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy Growth disclaims any obligation to update or revise any forward-looking statement. Readers are cautioned not to put undue reliance on any forward-looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

SOURCE Canopy Growth Corporation

Related Links

canopygrowth.com

This article appeared first on here.

Continue Reading
Advertisement TRENDING
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

FbMagazine

IBM Is Not Out of the Woods Yet

Published

on

On Thursday afternoon, International Business Corporation (NYSE: IBM) reported its weaker than expected fourth quarter, showing that its transformation struggles continue. The large software acquisition  of Red Hat that helps customers manage a growing hybrid cloud world while using AI to drive efficiency did not manage to bring the desired improvement. The pandemic led to an entirely different scenario and adjusted profits declined by nearly a third in 2020. Upon the results, stock fell more than 6% in after-hours trading. For the past year, Big Blue’s shares have declined 5.1% while the Dow Jones Industrial Average to which it is a member of, gained 6.8% with the S&P gaining 16% during the same period.

Q4 earnings

Net income was $1.36 billion, or $1.51 a share, which is significantly less than $4.11 a share in the same quarter last year and less than the $1.81 a share that analysts had expected. After taking away significant restructuring charges and similar effects, earnings amount to $2.07 a share, down from $4.79 a share in 2019’s quarter.

Analysts expected sales of $20.7 billion, but they shrank from $21.78 billion the year before to $20.37 billion. This is IBM’s lowest quarterly revenue since 1997. Looking at YoY figures, revenue has fallen 30 of the past 34 quarters. The only solace investors could possibly find is in the fact that Red Hat’s revenue increased 18% compared to last year’s quarter, but this wasn’t enough to move the needle.

2020 figures

Revenue dropped from $77.15 billion in 2019 to $73.62 billion, pulling down adjusted earnings from $12.81 a share to $8.67. Before COVID-19 started its relentless march across the globe, analysts expected adjusted earnings of $13.30 a share on sales of $79.4 billion, according to FactSet, but expectations took a sharp dive afterwards. The delivered results were even weaker. At the end of the day, companies are what their figures say they are and right now IBM’s record continues to trend in the wrong direction with shrinking earnings and sales.

2021 outlook

Although Big Blue will be getting smaller on purpose, the planned spinoff of the managed infrastructure business at the end of the year is expected to result in sustainable mid-single-digit revenue growth and a strong free cash flow. The spin-off, along with the $34 billion 2018 Red Hat acquisition and new Chief Executive Arvind Krishna are all parts of an effort to better position IBM in the cloud space which is ran by no other than Amazon (NASDAQ: AMZN), Microsoft (NASDAQ: MSFT) and Google (NASDAQ: GOOG)(NASDAQ: GOOGL). As if things weren’t hard enough.

IBM expects to grow revenue this year, but the story is more complicated than that. It will take a while before its strategic acquisition makes its way to improved top and bottom lines. Unfortunately, the overall picture is that revenue shrank for the fourth straight quarter, leaving the new executive sitting in the same chair as his predecessor who had 22 straight quarters of revenue losses under his watch. Despite Krishna’s sound approach, IBM’s efforts are simply not generating the expected growth, for now. But it is certainly too soon to say his transformation strategy has failed. However, something needs to change and as soon as possible.

This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure. IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: press@iamnewswire.com Contributors – IAM Newswire accepts pitches. If you’re interested in becoming an IAM journalist contact: contributors@iamnewswire.com

Continue Reading

FbMagazine

EV Efforts Needs to Catch Up to the Pace of Vaccine Development

Published

on

Science has done the impossible in an effort to combat COVID-19. But there is another technological challenge that is also vital to the planet’s health and it is to make better and more affordable batteries that will enable a wider EV adoption. Batteries need to become cheaper, they need to recharge faster, they need to adjust to a variety of temperatures and they need to last. There are many challenges but more than $300bn has been committed to EV efforts, according to Financial Times.

2020 was brilliant for EVs, despite the pandemic

The Guardian reported that sales of electric cars rose by 43% to more than 3 million, while overall car sales slumped by a fifth last year. Tesla (NASDAQ: TSLA), whose market capitalization of around $805 billion this week was higher than most of its rivals put together, led the race by selling almost half a million EVs. It was followed by Volkswagen (OTC: VWAGY) who sold more electric vehicles in western Europe last year than Tesla, despite VW’s struggles with the technology in recent years. In fact, sales of electric cars more than doubled in Europe, pushing the region past China as the world’s biggest market for them, according to Swedish-based firm, EV-volumes.com. December 2020’s sales were double compared to December 2019.

The equation is simple, EVs are better technology-wise than ICEs because there is no noise, no pollution, but there is better acceleration, and they are cheaper to run without running the environment. But, to truly replace traditional vehicles, more innovation is needed.

Innovations ahead

Worksport Ltd (OTC: WKSP) has recently added another trademark protection to its rich intellectual asset portfolio for TerraVis COR™. This innovative mobile battery system that is soon-to-be-launched is an extension to its TerraVis™ innovative truck tonneau cover system that brought solar-power to the EV equation. Another disruptive EV player is Ideanomics (NASDAQ: IDEX) which has a unique business model tailored to support a wider EV adoption. Its MEG segment effectively utilizes the S2F2C model in facilitating the switch for fleet operators to EVs. The company earns its revenue through a transaction fee for its holistic service that covers procurement, financing, and charging requirements. This is just one of several services that makes this company into a one-stop-shop for those looking to switch to EVs.

2021 – expectations are high

There is little time left to replace internal combustion engines. The UK aims to achieve this goal by 2030. The actual science behind EVs is very different from revolutionary mRNA technology used by Moderna Inc. (NASDAQ: MRNA), BioNTech (NASDAQ: BNTX) and Pfizer (NYSE: PFE) to develop their vaccines. Yet they have both one thing in common and that is the human brain that developed them. By successfully developing the vaccine to combat COVID-19 in less than a year, we won an even greater battle. People showed how far they can go when they come together to respond to an urging need. There’s no reason why developments battery technology won’t benefit from this same kind of synergy that is created when brilliant minds join forces. The money and enthusiasm are there to make yet another global public-private effort a success.

This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure. IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: press@iamnewswire.com Contributors – IAM Newswire accepts pitches. If you’re interested in becoming an IAM journalist contact: contributors@iamnewswire.com

Continue Reading

FbMagazine

Awaiting for Apple’s Earnings

Published

on

Apple (NASDAQ: AAPL) confirmed that its fiscal Q1 2021 results will be revealed on January 27th and Wall Street is getting excited. The new iPhone 12 could help to finally turn things around in Greater China where its sales have been falling apart since 2015.

The first financial report of the year is always Apple’s biggest in terms of revenue. For one thing, this quarter includes the holiday sales, but it also contains the first near-full quarter of sales for Apple’s annual flagship iPhone refresh. Launches of the iPhone 12 generation of smartphones that include the iPhone 12 mini, iPhone 12 Pro, and iPhone 12 Pro Max have reportedly seen such a high demand that Apple will allegedly increase production at the beginning of this year to a level that’s supposedly 30% higher than iPhone orders one year prior. But like the previous few quarters, this will be an unusual one with the ongoing pandemic. The Apple Watch Series 6, Apple Watch SE, and 2020 iPad, have been available for the entirety of the quarter, as opposed to the prior quarter which contained only a few days of this special trio.

Forecasts

Throughout 2020, Apple did not provide any guidance due to pandemic-related uncertainties. This practice will most likely remain in place as COVID-19 continues to wreak havoc on trade and supply chains across the globe. But, given the ongoing presence of social distancing measures that include working from home, revenue growth could still be in store for Mac and the iPad. This could be one of the last quarters of strong demand, before vaccines hopefully start putting an end to the global health crisis. Luckily for Apple, service revenues tend to be “sticky”, so this segment is unlikely to experience much of a decline going forward.

Previous quarter’s weak spots

The company failed to excite investors in its fourth quarter which ended September 26, 2020, due to weak iPhone sales. But this weakness was likely due to the fact that users were waiting for the new iPhone 12, which went on sale in October.

Outlook

Analysts expect revenues for the quarter to exceed $100 billion for the first time in its history. Morgan Stanley expects Apple to deliver all-time record revenue and earnings due to the strength across its product and services portfolio, driven by 5G adoption, remote work and learning, followed by sustained App Store engagement. Therefore, analysts expect double digit YoY growth for Apple’s five revenue segments in the December quarter.Apple’s services segment had a strong fiscal 2020, and the holiday quarter is likely to follow. Whether this will be the case, we will find out on Wednesday when Apple discloses the results of its critical first fiscal quarter for 2021.

This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure. IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: press@iamnewswire.com Contributors – IAM Newswire accepts pitches. If you’re interested in becoming an IAM journalist contact: contributors@iamnewswire.com

Continue Reading
Advertisement

TRENDING

Advertisement

Submit an Article

Send us your details and the subject of your article and an IAM editor will be in touch with you shortly

Trending